Search results
What’s driving the anti-vax movement? | The Excerpt
USA Today· 13 hours agoOn Sunday’s episode of The Excerpt podcast: Whether someone has or hasn’t been vaccinated for COVID-19, the measles, or even for polio, has become a...
Vaxcyte Inc (PCVX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Overview
GuruFocus.com via Yahoo Finance· 2 days agoEquity Financing: Completed a successful $862.5 million follow-on financing in February 2024, enhancing financial stability for ongoing and future projects. Upcoming Milestones ...
Infected blood company’s cost-cutting caused deadly polio epidemic
The Telegraph via Yahoo News· 3 hours agoA US laboratory that killed 10 children and gave 40,000 people polio went on to sell infected blood...
Could a Worm Really ‘Eat’ Part of RFK Jr.’s Brain? We Talked to a Neurologist
Rolling Stone via Yahoo News· 4 days agoSo, there you go. Brain worms: unfortunately real, definitely gross, but not as much cause for alarm...
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 5 days agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
Study: U.S. COVID Vax Campaign Saved Thousands Of Lives, Billions Of Dollars
MediaPost· 4 days agoBy the numbers, the U.S. government’s marketing campaign to get Americans vaccinated for COVID-19 was a resounding success, with new research proving that ads played an “indispensable” part ...
AstraZeneca recalls Covid vax: Risk-benefit currently against further use, say experts
Investing.com· 5 days agoNew Delhi, May 8 (IANS) The risk-benefit of AstraZeneca's Covid-19 vaccine is currently against...
COVID Vax Injuries Ignored? Obamacare for All Immigrants; Where Ticks Are Found
MedPage Today· 7 days agoThousands of Americans believe they suffered legitimate injuries from COVID vaccines but say they've...
Daily Brief: AstraZeneca halts its COVID vax
Quartz· 4 days agoThe U.K.-based pharma giant withdrew its European Union authorization to market the jab because of declining demand.
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 2 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...